MYC and neuroblastoma: Protein expression of c-MYC, pOCT4S111, and pMK2T334 was significantly higher in neuroblastoma PDXs (Supplementary Table 2) established at progressive disease compared with PDXs established at diagnosis (Fig. 7a, b).